Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against The Ensign Group, Inc. (ENSG) And Encourages Stockholders to Reach Out
NEW YORK CITY, NY / ACCESS Newswire / July 2, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Ensign Group, Inc. ("Ensign Group" or "the Company") (NASDAQ:ENSG). Investors who purchased Ensign Group securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ENSG.
Ensign Group Investigation Details
On June 8, 2026, Hunterbrook published a short report alleging that Ensign Group's business model relies on inadequate patient care and gaming quality metrics. The Hunterbrook report further alleges that Ensign Group's profits depend on understaffing facilities while routing taxpayer dollars to executives and affiliates, and that patients have suffered and died as a result. Following publication of the Hunterbrook report, Ensign Group's stock price fell $13.88 per share, or 8.15%, to close at $156.42 per share on June 8, 2026. Then, on June 11, 2026, Muddy Waters Research published a short report on Ensign Group, alleging possible Medicare and Medicaid fraud via a scheme to rent licenses of administrators of skilled nursing facilities who are not actually managing the facilities, potentially in violation of the False Claims Act.
Following publication of the Muddy Waters report, Ensign's stock price fell $4.52 per share, or 2.98%, to close at $147.13 per share on June 11, 2026.
What's Next for Ensign Group Investors?
If you are aware of any facts relating to this investigation or purchased Ensign Group securities, you can assist this investigation by visiting the firm's site: bgandg.com/ENSG. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 917-590-0911
No Cost to Ensign Group Investors
We, Bronstein, Gewirtz & Grossman, LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman, LLC for Ensign Group Securities Investigation?
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.
Follow us for updates on LinkedIn, X, Facebook, or Instagram.
Contact Info
Peretz Bronstein, Esq. or Nathan Miller
Bronstein, Gewirtz & Grossman, LLC
917-590-0911 | [email protected]
Attorney advertising.
Prior results do not guarantee similar outcomes.
SOURCE: Bronstein, Gewirtz & Grossman, LLC